Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Andreas Rafail Vasileiou has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Enhancing Gut Microbiome and Metabolic Health in Mice Through Administration of Presumptive Probiotic Strain Lactiplantibacillus pentosus PE11

    by Ioanna Farmakioti, Electra Stylianopoulou, Nikistratos Siskos, Evangelia Karagianni, Dionysios Kandylas, Andreas Rafail Vasileiou, Fragkiski Fragkiskatou, Paraskevi Somalou, Alexandra Tsaroucha, Petros Ypsilantis, et al.

    Background: Over the past decade, probiotics have gained increasing recognition for their health benefits to the host. While most research has focused on the therapeutic effects of probiotics in the treatment of various diseases, recent years have seen a shift towards exploring their role in enhancing and supporting overall health. Methods: In this work, we have studied the effects of a novel potential probiotic strain, Lactiplantibacillus pentosus PE11, in healthy mice following a six-week dietary intervention. The assessment included monitoring the general health of the animals, biochemical analyses, profiling of the gut and fecal microbial communities, and gene expression analysis. Results: Our results showed that the administration of Lactiplantibacillus pentosus PE11 led to changes in the composition of the fecal microbiome, specifically an increase in the Firmicutes/Bacteroidetes ratio and in the relative abundance of the Lachnospiraceae, Ruminococcaceae, and Rikenellaceae families. Reduced Tnf expression and elevated Zo1 expression were also observed in the cecum, pointing to anti-inflammatory properties and improved intestinal barrier integrity. Additionally, a significant reduction in triglycerides and alanine aminotransferase levels—within physiological ranges—was observed, along with a trend toward decreased total cholesterol levels. Conclusions: These findings suggest that in healthy mice, Lactiplantibacillus pentosus PE11 has the potential to positively influence gut microbiome structure and metabolism, thereby supporting improved overall health.


  • Open Access

    Enhancing Gut Microbiome and Metabolic Health in Mice Through Administration of the Presumptive Probiotic Strain Lactiplantibacillus pentosus PE11

    by Ioanna Farmakioti, Electra Stylianopoulou, Nikistratos Siskos, Evangelia Karagianni, Dionysios Kandylas, Andreas Rafail Vasileiou, Fragkiski Fragkiskatou, Paraskevi Somalou, Alexandra Tsaroucha, Petros Ypsilantis, et al.

    Over the past decade, probiotics have gained increasing recognition for their health benefits to the host. While most research has focused on the therapeutic effects of probiotics in the treatment of various diseases, recent years have seen a shift towards exploring their role in enhancing and supporting overall health. In this work, we have studied the effects of a novel potential probiotic strain, Lactiplantibacillus pentosus PE11, in healthy mice following a six-week dietary intervention. The assessment included monitoring the general health of the animals, biochemical analyses, profiling of the gut and fecal microbial communities and gene expression analysis. Our results showed that the administration of Lactiplantibacillus pentosus PE11 led to significant changes in the composition of the fecal microbiome, specifically an increase in the Firmicutes/Bacteroidetes ratio and in the relative abundance of the Lachnospiraceae, Ruminococcaceae and Rikenellaceae families. Additionally, a significant reduction in triglyceride and alanine aminotransferase levels was observed, along with a trend toward decreased total cholesterol levels. Our results suggest that in healthy mice Lactiplantibacillus pentosus PE11 has the potential to positively influence gut microbiome structure and metabolism, thereby supporting improved overall health.

  • Open Access

    Characterization of the Abracl-Expressing Cell Populations in the Embryonic Mammalian Telencephalon

    by Dimitrios Troumpoukis, Andreas Rafail Vasileiou, Nikistratos Siskos, Electra Stylianopoulou, Petros Ypsilantis, George Skavdis, Maria E. Grigoriou

    Abracl (ABRA C-terminal-like protein) is a small, non-typical winged-helix protein that shares similarity with the C-terminal domain of the protein ABRA (Actin-Binding Rho-Activating protein). The role of Abracl in the cell remains elusive, although in cancer cells, it has been implicated in proliferation, migration and actin dynamics. Our previous study showed that Abracl mRNA was expressed in the dividing cells of the subpallial subventricular zone (SVZ), in the developing cortical plate (CP), and in the diencephalic SVZ; however, the molecular identities of the Abracl-expressing cell populations were not defined in that work. In this study, we use double immunofluorescence to characterize the expression of Abracl on sections of embryonic murine (E11.5-E18.5) and feline (E30/31-E33/34) telencephalon; to this end, we use a battery of well-known molecular markers of cycling (Ki67, Ascl1, Dlx2) or post-mitotic (Tubb3, Gad65/67, Lhx6 and Tbr1) cells. Our experiments show that Abracl protein has, compared to the mRNA, a broader expression domain, including, apart from proliferating cells of the subpallial and diencephalic SVZ, post-mitotic cells occupying the subpallial and pallial mantle (including the CP), as well as subpallial-derived migrating interneurons. Interestingly, in late embryonic developmental stages, Abracl was also transiently detected in major telencephalic fiber tracts.